Want to join the conversation?
$MET 2Q15 Call: Operating earnings were $1.8Bil, up 11% from 2Q14 and operating earnings per share were $1.56, a 12% increase over 2Q14. Operating return on equity was 12.5% & tangible return on equity was 15.3%. 2Q15 results were negatively impacted by strong dollar. Operating earnings grew 11% on a reported basis & 16% on constant currency basis.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.